Inotiv (NOTV) Total Non-Current Liabilities (2014 - 2026)
Inotiv (NOTV) reported Total Non-Current Liabilities of $595.8 million for Q1 2026, up 4.35% on a YoY basis from $570.9 million in Q1 2025, and little changed quarter-over-quarter from $597.2 million in Q4 2025.
Inotiv (NOTV) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Inotiv has reported Total Non-Current Liabilities for 10 years, with the latest figure at $595.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 4.35% year-over-year to $595.8 million; the trailing twelve-month figure through Mar 2026 stood at $595.8 million (up 4.35% YoY), and the FY2025 full-year result was $606.7 million, up 5.35% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $595.8 million, roughly flat from $597.2 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $606.7 million in Q3 2025, with the low at $520.1 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $576.1 million across 5 years, with a median of $575.9 million in 2024.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 175.95% — and 2023, when it slipped 3.73%.
- Inotiv's Total Non-Current Liabilities stood at $585.2 million in 2022, then fell by 3.73% to $563.4 million in 2023, then increased by 0.77% to $567.7 million in 2024, then rose by 5.19% to $597.2 million in 2025, then retreated by 0.23% to $595.8 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $595.8 million (Q1 2026), $597.2 million (Q4 2025), and $606.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Inotiv | 3.24 Mn | -11.94 Mn | 111.99 Mn | 595.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 595.79 Mn |
| Dec 31, 2025 | 597.17 Mn |
| Sep 30, 2025 | 606.70 Mn |
| Jun 30, 2025 | 588.39 Mn |
| Mar 31, 2025 | 570.95 Mn |
| Dec 31, 2024 | 567.72 Mn |
| Sep 30, 2024 | 575.89 Mn |
| Jun 30, 2024 | 557.57 Mn |
| Mar 31, 2024 | 570.16 Mn |
| Dec 31, 2023 | 563.38 Mn |
| Sep 30, 2023 | 581.67 Mn |
| Jun 30, 2023 | 573.59 Mn |
| Mar 31, 2023 | 590.01 Mn |
| Dec 31, 2022 | 585.18 Mn |
| Sep 30, 2022 | 596.66 Mn |
| Jun 30, 2022 | 552.63 Mn |
| Mar 31, 2022 | 520.10 Mn |
| Dec 31, 2021 | 410.19 Mn |
| Sep 30, 2021 | 216.22 Mn |
| Sep 30, 2017 | 11.95 Mn |